Dysplastic nevi. Markers for increased risk for melanoma. 1989

D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
Department of Dermatology, New York University School of Medicine, New York.

A total of 452 white patients, classified into four dysplastic nevi groups, were followed prospectively by repetitive, complete cutaneous examinations using total-body photographs taken on entry into the study. Sixteen patients (3.5%) developed 18 newly diagnosed malignant melanomas (MM) during an average follow-up period of 27 months. Twelve of the 18 MM were in situ, and all of the six primary invasive MM diagnosed prospectively in this follow-up were less than 0.89 mm in Breslow thickness, implying an excellent prognosis. Compared with reference populations, the number of MM detected significantly exceeded the number estimated to occur in the comparable age-matched control groups. These data support the concept of repetitive follow-ups of all groups of patients with dysplastic nevi.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004416 Dysplastic Nevus Syndrome Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed) B-K Mole Syndrome,Familial Atypical Multiple Mole-Melanoma,Nevus Syndrome, Dysplastic,Nevus, Dysplastic,Dysplastic Nevi,B K Mole Syndrome,Dysplastic Nevus,Familial Atypical Multiple Mole Melanoma,Nevi, Dysplastic,Syndrome, B-K Mole,Syndrome, Dysplastic Nevus
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
December 1996, Seminars in oncology,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
January 1990, Journal of the American Academy of Dermatology,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
October 1987, The Western journal of medicine,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
January 2012, PloS one,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
January 1996, European journal of ophthalmology,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
July 1991, Archives of dermatology,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
May 1989, New Jersey medicine : the journal of the Medical Society of New Jersey,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
April 2013, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
May 1988, Preventive medicine,
D S Rigel, and J K Rivers, and A W Kopf, and R J Friedman, and A F Vinokur, and E R Heilman, and M Levenstein
January 2006, ACP journal club,
Copied contents to your clipboard!